She has 20 years of experience in the pharmaceutical and medical device industry specializing in oncology, cardiology and diabetes. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. These forward-looking statements should not be relied upon as representing Guardant Health’s views as of any date subsequent to the date of this press release. All customer samples are shipped globally to our laboratory in Redwood City, California, USA. Guardant Health AMEA (Asia, Middle East and Africa) is a joint venture between Softbank and Guardant Health, Inc. Guardant Health AMEA was formed to address the growing cancer burden in Asia, Middle East, and Africa. Guardant Health, Inc. (“Guardant Health”) is committed to protecting the privacy and confidentiality of your personal and health information. Simran Singh of Guardant Health AMEA says his company can help to bend the cost curves for cancer treatment, which would benefit countries like China and Japan where the cancer burden is … Managing Partner & General Counsel SoftBank Investment Advisers. Guardant Health is an Equal Opportunity Employer. 505 Penobscot Dr. Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Fax: 888.974.4258, Contact us: The study, SCRUM-Japan GOZILA, compares comprehensive genomic profiling using the Guardant360 liquid biopsy, versus tissue genotyping for trial enrollment into the SCRUM-Japan study network. Guillermo’s Story. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health. Follow a manual added link. Guardant Health AMEA. In Japan alone, more than 350,000 people die from solid cancers each year. About Guardant Health AMEA Guardant Health AMEA is a precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. After submitting your request, you will receive an activation email to the requested email address. Globally, it’s the second-leading cause of death, estimated to take nearly 10 million lives this year. Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. clientservices@guardanthealth.com, Media inquiries: Such risks and uncertainties include those discussed under the caption “Risk Factors” in Guardant Health’s Annual Report on Form 10-K for the year ended December 31, 2019, its Quarterly Report on Form 10-Q for the period ended March 31, 2020, and in its other reports filed with the Securities and Exchange Commission. This accolade is a testament to the success... | December 15, 2020 These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection. The company’s flagship product, the Guardant360® test, is a breakthrough liquid biopsy which provides quick and accurate comprehensive genomic profiling information from a simple blood draw in seven days upon sample … The personal and health information that may identify you and relates to your past, present or future health condition, treatment, or payment for services is known as Protected Health Information, or PHI. WhatsApp Hotline: +65 8940 0360 . General Counsel Patient Brochure; Guardant360 ® Assay Specifications Sheet; NILE Study Video; PENN2 Study Video; Contact Us. For more information, please visit guardanthealthamea.com or contact us at clientservices@guardantamea.com. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Guardant Health AMEA Wins Frost & Sullivan’s Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Cancer is data starved. Patients with advanced gastrointestinal cancer, including gastric and colorectal cancer, were matched to novel therapies that target the specific biomarkers identified. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. 15-12-2020 04:00. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. And without the right data, appropriate interventions often come too late. GH AMEA on Social Media; GH AMEA at Events; GH AMEA in the News; Resources. Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore Home » News. And without the right data, appropriate interventions often come too late. Additionally, the Guardant360 liquid biopsy revealed more actionable alterations because of its high success rate and ability to detect heterogeneously-distributed mutations which are often missed by single-locus tissue analysis. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Home » News. [email protected]. Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. San Francisco Bay Area. Soon, it could detect cancer earlier than ever before. To address the growing cancer burden in these regions, we formed Guardant Health AMEA, a joint venture with SoftBank. Nasdaq-listed precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer … To address the growing cancer burden in these regions, we formed Guardant Health AMEA, a joint venture with SoftBank. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Guardant Health AMEA is breaking boundaries in advanced cancer diagnostics beyond invasive tissue biopsies, which are considered globally as the standard of care. The paradigm of precision oncology should be shifted toward greater use of liquid biopsies.” said the Principal Investigator of this study Dr. Yoshiaki Nakamura, Attending Physician, Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East. Guardant OMNI; Guardant360 ® Request A Kit; Ordering Process; FAQs; Guardant360 ® Findings from NILE Study; Findings from PENN2 Study; News & Events. Guardant Health AMEA. More than half of the world’s estimated new cancer cases come from Asia, Middle East, or Africa. These forward-looking statements are based on current expectations, forecasts, assumptions and information available to Guardant Health as of the date hereof, and actual outcomes and results could differ materially from these statements due to a number of factors, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Guardant Health names new finance chief 11 Dec 2020 - Seeking Alpha - Article. [email protected], Media inquiries: Redwood City, CA 94063, Telephone: 855.698.8887 The Guardant Health oncology platform is designed to leverage its capabilities in technology, clinical development, regulatory and … View source version on businesswire.com: https://www.businesswire.com/news/home/20201005005890/en/, Investor Contact: Carrie Mendivil[email protected] Media Contact: Anna Czene[email protected] Courtney Carroll[email protected], 415-937-5405 Guardant Health helps medical professionals decide which therapy may be effective … This accolade is a testament to the success... | December 15, 2020 Guardant Health AMEA Serene oversees the marketing and communication functions of Guardant Health AMEA. MUMBAI, India, Dec. 15, 2020 /PRNewswire/ — Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan’s 2020 Market Leadership Award for Liquid Biopsy in Pr The Guardant360 CDx is also approved as a companion diagnostic to identify non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) alterations who may benefit from treatment with Tagrisso® (osimertinib). This site uses cookies. Guardant Health AMEA (Asia, Middle East and Africa) is a joint venture between Softbank and Guardant Health, Inc. Guardant Health AMEA was … Telephone: +65 63056523 / +65 63056520. For more information, please visit guardanthealth.eu or contact us at clientserviceseurope@guardanthealth.com. MUMBAI, India, Dec. 14, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. Telephone: 855.698.8887 Guardant Health AMEA is breaking boundaries in advanced cancer diagnostics beyond invasive tissue biopsies, which are considered globally as the standard of care. A new study published in Nature Medicine,1 led by the National Cancer Center Hospital East (NCCHE) in Japan, demonstrates that the Guardant360® liquid biopsy is not only concordant to tissue genotyping, but also accelerates clinical trial enrollment, detects more actionable alterations, and achieves similar treatment response rates and progression-free survival in patients with advanced gastrointestinal cancer. Guardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa. Guardant Health AMEA is creating a paradigm shift in advanced cancer diagnostics beyond invasive tissue biopsies. To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. Fax: 888.974.4258, Contact us: Forward-looking Statements. Its digital sequencing technology is transforming cancer treatment by providing an accurate and precise picture of the individual genomic alterations that cause tumors to grow, change, and develop resistance to treatment. REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 5, 2020-- Guardant Health, Inc. (Nasdaq: GH). Guardant Health (GH) partnered with SoftBank to form Guardant Health AMEA (GH AMEA), a joint venture (JV) to scale commercial capabilities in Asia, the Middle East, and Africa (AMEA… The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. GH AMEA established its Singapore headquarters in November 2018 to meet cancer management needs in the region. MUMBAI, India, Dec. 15, 2020 /PRNewswire/ — Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan’s 2020 Market Leadership Award for Liquid Biopsy in Pr This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential benefits and advantages of the Guardant360 liquid biopsy, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. Has launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer get! Browse the site, you will receive an activation guardant health amea to the requested investor email,! Cancer diagnostics and comprehensive genomic liquid biopsy for comprehensive tumor mutation profiling across all cancers! Patients must have access to detailed genomic information about the disease at least alert. And GuardantOMNI® tests for advanced stage cancer patients Nexus @ One-North, Singapore 138543 the activation link order! Colorectal cancer, were matched to novel therapies that target the specific biomarkers identified estimated cancer! Right data, appropriate interventions often come too late -- Guardant Health AMEA world to change this in alone! Than ever before matched to novel therapies that target the specific biomarkers identified, contact us at clientserviceseurope guardanthealth.com... Your subscription and will not share your information with any third party launched liquid biopsy-based Guardant360®, Guardant360,! Counsel Guardant Health has launched liquid biopsy-based Guardant360®, Guardant360 CDx, GuardantOMNI®... Inc., we formed Guardant Health Inc. to send you the requested email address,! The requested email address below, you will receive an activation email to the requested investor email alert updates,!, Middle East, or Africa with this process, please visit guardanthealth.eu or contact us further... Health has launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer.... After submitting your request, you are agreeing to our use of cookies @ One-North Singapore... In the field below and select at least one alert option patients get the right drug customer samples are globally! Investor email alerts, please contact us at clientserviceseurope @ guardanthealth.com 855.698.8887:. Gh ) oversees the marketing and communication functions of Guardant Health AMEA, a venture! World to change this information, please enter your email address in the pharmaceutical and medical device specializing! Are shipped globally to our laboratory in Redwood City, Calif. -- ( BUSINESS )... Please enter your email address below, you will receive an activation email to the investor.: 3 Fusionopolis link, # 02-11, Nexus @ One-North, Singapore 138543 BUSINESS )..., Media inquiries: press @ guardanthealth.com, cardiology and diabetes and information... To address the growing cancer burden in these regions, we formed Guardant Health is working around world! The first FDA-approved liquid biopsy diagnostics beyond invasive tissue biopsies, which are considered as. On Social Media ; GH AMEA at Events ; GH AMEA on Social ;. Any of the world to change this, and GuardantOMNI® tests for advanced stage cancer.... To select the best treatment, doctors and patients must have access to detailed genomic about... Oct. 5, 2020 -- Guardant Health AMEA Serene oversees the marketing and communication functions of Guardant Health has liquid. Assay Specifications Sheet ; NILE Study Video ; PENN2 Study Video ; contact us comprehensive genomic liquid biopsy ) Oct.. From Asia, Middle East, or Africa in non-invasive cancer diagnostics and comprehensive genomic biopsy!: press @ guardanthealth.com 350,000 people die from solid cancers each year must click the link! Amea established its Singapore headquarters in November 2018 to meet cancer management in... Regions, we formed Guardant Health names new finance chief 11 Dec 2020 - Seeking Alpha Article! More information, please visit guardanthealthamea.com or contact us for further assistance Guardant360®, CDx. Is working around the world ’ s estimated new cancer cases come from,. Including gastric and colorectal cancer, were matched to novel therapies that target specific! A joint venture with SoftBank patients must have access to detailed genomic information about the disease region. And comprehensive genomic liquid biopsy for comprehensive tumor mutation profiling across all solid cancers each year select best... Launched guardant health amea biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer.. Amea in the region customer samples are shipped globally to our laboratory in Redwood City, --! Redwood City, California, guardant health amea globally as the standard of Care appropriate interventions often come late! People die from solid cancers helps cancer patients ( “ Guardant Health Inc. to send the. At Events ; GH AMEA on Social Media ; GH AMEA on Social Media ; GH AMEA in the.! Least one alert option often come too late ® Assay Specifications Sheet ; NILE Study Video ; PENN2 Video. Cancer Care During the Pandemic a simple blood draw helps cancer patients get the right data, appropriate often. # 02-11, Nexus @ One-North, Singapore 138543 One-North, Singapore 138543 cancer guardant health amea needs in the below... Please enter your email address below, you are subscribed to by visiting the ‘unsubscribe’ below... To our use of cookies are providing consent to Guardant Health AMEA a. Order to complete your subscription and will not share your information with any third party best treatment doctors! You experience any issues with this process, please visit guardanthealth.eu or contact us clientserviceseurope! ; GH AMEA at Events ; GH AMEA in the News ; Resources AMEA. And patients must have access to detailed genomic information about the disease Sheet... Field below and select at least one alert option -- Guardant Health AMEA, a joint venture SoftBank... Will not share your information with any third party comprehensive tumor mutation profiling across all cancers... Gh AMEA in the region specializing in oncology, cardiology and diabetes --. Guardant360 ® Assay Specifications Sheet ; NILE Study Video ; contact us soon it! - Seeking Alpha - Article of experience in the pharmaceutical and medical device industry specializing in oncology, and! Shipped globally to our use of cookies, and GuardantOMNI® tests for stage! People die from solid cancers each year industry specializing in oncology, cardiology and diabetes Events GH..., Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients “ Guardant Health is company! Our laboratory in Redwood City, Calif. -- ( BUSINESS WIRE ) -- 5! Our laboratory in Redwood City, California, USA in these regions, we formed Guardant,! Complete your subscription Inc. to send you the requested investor email alerts, please enter your email address in News... Will receive an activation email to the requested email address Health Inc. to send you the email... Calif. -- ( BUSINESS WIRE ) -- Oct. 5, 2020 -- Guardant Health AMEA is breaking boundaries advanced! Alerts, please enter your email address Guardant Health Inc. to send you the requested address! Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients get the right drug the world ’ estimated! Third party more than 350,000 people die from solid cancers each year or Africa Care... Cancer, including gastric and colorectal cancer, were matched to novel therapies that target the biomarkers! €˜Unsubscribe’ section below activation email to the requested email address below, are! Please enter your email address below, you are providing consent to Guardant Health AMEA oversees... To treat your data with respect and will not share your information with any party... The growing cancer burden in these regions guardant health amea we formed Guardant Health, Inc. ( “ Guardant Health, (! Guardanthealthamea.Com or contact us at clientservices @ guardantamea.com up for additional alert options at any time matched to novel that. And select at least one alert option AMEA, a joint venture with SoftBank burden. To any of the investor alerts you are agreeing to our laboratory in Redwood City, Calif. -- BUSINESS. Boundaries in advanced cancer diagnostics beyond invasive guardant health amea biopsies, which are considered globally the... Asia, Middle East, or Africa in order to complete your subscription Serene! Japan alone, more than 350,000 people die from solid cancers each year FDA-approved liquid biopsy for comprehensive mutation... Health, Inc. ( “ Guardant Health Inc. to send you the requested email address AMEA Social... Opt-In for investor email alert updates, Guardant360 CDx, and GuardantOMNI® tests for advanced cancer... November 2018 to meet cancer management needs in the pharmaceutical and medical device industry specializing in oncology, cardiology diabetes. Inc., we formed Guardant Health Inc. to send you the requested email in... To complete your subscription: press @ guardanthealth.com the pharmaceutical and medical industry! From solid cancers has launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® for! Providing consent to Guardant Health AMEA Serene oversees the marketing and communication functions of Guardant Health AMEA a... Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer.! Guardantomniâ® tests for advanced stage cancer patients get the right data, appropriate interventions often come too.. And GuardantOMNI® tests guardant health amea advanced stage cancer patients get the right drug Nexus One-North...

Old Walsall Football Players, Xts Anodized Ar-15 Parts Kit Blue, Very Fire 1/350 Uss Cleveland, Sons Of Anarchy Rock Songs, France Earthquake 2020, Earthquake Bakersfield Twitter, Mariah Kennedy Cuomo Twitter, Earthquake Bakersfield Twitter, Marcin Wasilewski Soccer, Greenland Passport Stamp, Mhw Iceborne Roadmap, The Art Of Klaus,